Search - tctmd.com

Displaying 441 - 460 of 900

Sort: Relevancy | Date

News Daily News

Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds

Yael L. Maxwell

January 25, 2019

News Daily News

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

Caitlin E. Cox

January 24, 2019

News Daily News

More Insurance Following Medicaid Expansion, but Acute MI Survival Remained Static

Yael L. Maxwell

January 18, 2019

News Daily News

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Todd Neale

January 18, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Michael O'Riordan

January 11, 2019

News Daily News

Flu Tied to Worse Outcomes in Patients Hospitalized With Heart Failure

Todd Neale

January 03, 2019

News Daily News

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Yael L. Maxwell

January 02, 2019

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

L.A. McKeown

December 21, 2018

News Daily News

FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering

Yael L. Maxwell

December 19, 2018

News Daily News

Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure

Yael L. Maxwell

December 17, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Are the Best Hospitals Actually the Best? Analysis Looks at US News & World Report Rankings

Yael L. Maxwell

November 28, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

Advertisement

Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds

Aspirin as Primary Prevention Curbs CV Events but Ups Major Bleeding, Too: Meta-analysis

More Insurance Following Medicaid Expansion, but Acute MI Survival Remained Static

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Flu Tied to Worse Outcomes in Patients Hospitalized With Heart Failure

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Top News in Clinical Cardiology: 2018

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering

Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Are the Best Hospitals Actually the Best? Analysis Looks at US News & World Report Rankings

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content